Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary K Downer

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
JAMA Oncology|May 12, 2017
Declining Incidence Rates of Prostate Cancer in the United States: Is This Good News or Not?Mary K Downer, Meir J Stampfer, Matthew R Cooperberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2017
Vasectomy and Risk of Prostate Cancer: How to Weigh Current EvidenceClaire H Pernar, Mary K Downer, Kathryn M Wilson, et al.
European Urology|June 19, 2016
Should We Fear Folate?Mary K Downer, Erin L Van Blarigan, Sam F Peisch, et al.
Neuro-Oncology|March 25, 2017
ABO blood group and risk of gliomaDavid J Cote, Mary K Downer, Emilie S Zoltick, et al.
Cancer Causes & Control : CCC|June 27, 2018
Height, waist circumference, body mass index, and body somatotype across the life course and risk of gliomaDavid J Cote, Mary K Downer, Timothy R Smith, et al.
The Prostate|June 19, 2019
Circulating inflammation markers and prostate cancerHenrik Ugge, Mary K Downer, Jessica Carlsson, et al.
Cancer Causes & Control : CCC|June 20, 2018
Regular aspirin use and gene expression profiles in prostate cancer patientsKonrad H Stopsack, Ericka M Ebot, Mary K Downer, et al.
European Urology|February 13, 2017
Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health StudyMary K Downer, Christopher B Allard, Mark A Preston, et al.
European Urology Oncology|April 25, 2019
Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up StudyMary K Downer, Christopher B Allard, Mark A Preston, et al.
Obstetrics and Gynecology|October 6, 2022
Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian CancerSarah P Huepenbecker, Jason D Wright, Mary K Downer, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
JAMA Oncology|May 12, 2017
Declining Incidence Rates of Prostate Cancer in the United States: Is This Good News or Not?Mary K Downer, Meir J Stampfer, Matthew R Cooperberg
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2017
Vasectomy and Risk of Prostate Cancer: How to Weigh Current EvidenceClaire H Pernar, Mary K Downer, Kathryn M Wilson, et al.
European Urology|June 19, 2016
Should We Fear Folate?Mary K Downer, Erin L Van Blarigan, Sam F Peisch, et al.
Neuro-Oncology|March 25, 2017
ABO blood group and risk of gliomaDavid J Cote, Mary K Downer, Emilie S Zoltick, et al.
Cancer Causes & Control : CCC|June 27, 2018
Height, waist circumference, body mass index, and body somatotype across the life course and risk of gliomaDavid J Cote, Mary K Downer, Timothy R Smith, et al.
The Prostate|June 19, 2019
Circulating inflammation markers and prostate cancerHenrik Ugge, Mary K Downer, Jessica Carlsson, et al.
Cancer Causes & Control : CCC|June 20, 2018
Regular aspirin use and gene expression profiles in prostate cancer patientsKonrad H Stopsack, Ericka M Ebot, Mary K Downer, et al.
European Urology|February 13, 2017
Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health StudyMary K Downer, Christopher B Allard, Mark A Preston, et al.
European Urology Oncology|April 25, 2019
Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up StudyMary K Downer, Christopher B Allard, Mark A Preston, et al.
Obstetrics and Gynecology|October 6, 2022
Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian CancerSarah P Huepenbecker, Jason D Wright, Mary K Downer, et al.
Pageof 2